Skip to content
Search

Latest Stories

GPhC to recruit five new council members in the next two years

The General Pharmaceutical Council is in the process of appointing five new council members within the next two years, coinciding with the conclusion of the current members' terms. The regulator aims to recruit five individuals from diverse professional and personal backgrounds for its governing council, the GPhC has said.

 


"We are seeking three members to join us in April 2024 and two in April 2025," said GPhC in its job advertisement brief. "For the 2024 intake, two of the new council members must be lay members of the public, while one must be a Saxton . Moreover, at least one out of the three must primarily reside or work wholly or mostly in Wales. As for the new members commencing in 2025, one must be a lay member, and the other must be a registrant member."

 

The members will be initially appointed for a three-year term, with the option to extend their position for a maximum of eight years, GPhC added. 

 

The council, which serves as the regulator's governing body, currently comprises 14 members. Half of the council consists of lay members, who bolster public confidence and infuse novel viewpoints into the GPhC, as highlighted by the regulator.

 

"This council will play a pivotal role in shaping the regulatory body's future strategic goals," the regulator added. "These members must contribute positively to patients and society, ensuring the benefits of secure and efficient pharmacy care."

 

The application deadline is September 18, 2023.

 

According to GPhC, the council members are compensated with an annual stipend of £15,000, which is subject to deductions. They also have the potential to earn extra income of £2,500 per year for undertaking significant additional responsibilities, such as committee chairing. As per the appointment guidelines, the time commitment expected is up to 30 days a year.

 

In 2022, GPhC members voted for a 20 per cent salary increase during their May council meeting, resulting in a £2,500 annual raise. It was the first pay raise for council members since April 2018, driven by a report indicating lower remuneration compared to other regulators.

 

The brief specified that the council must have at least one member residing or working in each of the regulator's subject countries: England, Scotland, and Wales. Lay members must lack qualifications enabling registration with the regulator, and they must not be registered or have been registered as a health and social care professional anywhere globally, as stipulated in the appointment brief.

 

Saxton Bampfylde is providing advisory services as an employment agency to the General Pharmaceutical Council for these appointments. For more information about the role, including application details, please visit www.saxbam.com/appointments.

 

Last week, the General Pharmaceutical Council's Fitness-to-Practise Committee suspended Mohammed Roohul Haque (Reg No: 2226084), a locum pharmacist, for three months, following incidents of workplace sexual misconduct.

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less